Virulence factors of Candida albicans

RA Calderone, WA Fonzi - Trends in microbiology, 2001 - cell.com
Candidiasis is a common infection of the skin, oral cavity and esophagus, gastrointestinal
tract, vagina and vascular system of humans. Although most infections occur in patients who …

Candida albicans: A molecular revolution built on lessons from budding yeast

J Berman, PE Sudbery - Nature Reviews Genetics, 2002 - nature.com
Candida albicans is an opportunistic fungal pathogen that is found in the normal
gastrointestinal flora of most healthy humans. However, in immunocompromised patients …

Engineered Control of Cell Morphology In Vivo Reveals Distinct Roles for Yeast and Filamentous Forms of Candida albicans during Infection

SP Saville, AL Lazzell, C Monteagudo… - Eukaryotic …, 2003 - Am Soc Microbiol
It is widely assumed that the ability of Candida albicans to switch between different
morphologies is required for pathogenesis. However, most virulence studies have used …

Large‐scale essential gene identification in Candida albicans and applications to antifungal drug discovery

T Roemer, B Jiang, J Davison, T Ketela… - Molecular …, 2003 - Wiley Online Library
Candida albicans is the primary fungal pathogen of humans. Despite the need for novel
drugs to combat fungal infections [Sobel, JD (2000) Clin Infectious Dis 30: 652], antifungal …

Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis

BM Peters, GE Palmer, AK Nash, EA Lilly… - Infection and …, 2014 - Am Soc Microbiol
Vulvovaginal candidiasis, caused primarily by Candida albicans, presents significant health
issues for women of childbearing age. As a polymorphic fungus, the ability of C. albicans to …

Expression levels of a filament-specific transcriptional regulator are sufficient to determine Candida albicans morphology and virulence

PL Carlisle, M Banerjee, A Lazzell… - Proceedings of the …, 2009 - National Acad Sciences
Candida albicans, the major human fungal pathogen, undergoes a reversible morphological
transition from single yeast cells to pseudohyphal and hyphal filaments (elongated cells …

Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs

CG Pierce, JL Lopez-Ribot - Expert opinion on drug discovery, 2013 - Taylor & Francis
Introduction: Targeting pathogenetic mechanisms, rather than essential processes,
represents a very attractive alternative for the development of new antibiotics. This may be …

Systems-level antimicrobial drug and drug synergy discovery

T Roemer, C Boone - Nature chemical biology, 2013 - nature.com
Here, we review the'target-centric'genomic strategy to antimicrobial discovery and share our
perspective on identification, validation and prioritization of potential antimicrobial drug …

Outer chain N-glycans are required for cell wall integrity and virulence of Candida albicans

S Bates, HB Hughes, CA Munro, WPH Thomas… - Journal of Biological …, 2006 - ASBMB
The outer layer of the Candida albicans cell wall is enriched in highly glycosylated
mannoproteins that are the immediate point of contact with the host and strongly influence …

Glucose Promotes Stress Resistance in the Fungal Pathogen Candida albicans

A Rodaki, IM Bohovych, B Enjalbert… - Molecular biology of …, 2009 - Am Soc Cell Biol
Metabolic adaptation, and in particular the modulation of carbon assimilatory pathways
during disease progression, is thought to contribute to the pathogenicity of Candida …